Press Releases

03/27/2019

‘IVI Forum for Enhancement of Cooperation’ hosted jointly by the Korean Parliamentary Forum for Global Health, and KCDC under MOHW

– Event organized by IVI to discuss ways of cooperation to help increase Korea’s vaccine self-sufficiency, and accelerate globalization of the Korean vaccine industry Key participants pose for a commemorative photo at the ‘IVI Forum for Enhancement of Cooperation’ at the National Assembly of the […]
04/17/2019

IVI receives $15.7 million grant to conduct phase III trials of new Vi-DT typhoid conjugate vaccine manufactured by SK bioscience of Korea

– Grant from the Bill & Melinda Gates Foundation will support additional supply of novel TCV at affordable cost for public sector markets   SEOUL, Korea –The International Vaccine Institute (IVI) announces receipt of a $15.7 million-dollar grant from the Bill & Melinda Gates Foundation […]
04/18/2019

IVI-led CAPTURA consortium wins Fleming Fund award for work on antimicrobial resistance (AMR) data across Asia

SEOUL, South Korea — An international consortium, led by the International Vaccine Institute (IVI), has received funding from the UK’s Fleming Fund Regional Grants to conduct the Capturing Data on Antimicrobial Resistance (AMR) Patterns and Trends in Use in Regions of Asia (CAPTURA) project. The […]
05/30/2019

New push to develop world’s first vaccine against the deadly Strep A bacteria killing hundreds of thousand

Streptococcus pyogenes bacteria, which causes scarlet fever and other infections   30 May 2019, SEOUL, South Korea – The International Vaccine Institute (IVI) and Australia’s Murdoch Children’s Research Institute (MCRI) will coordinate a global push to free the world of Group A Streptococcus (Strep A), […]